The factors affect the antibody answer to recombinant hepatitis B vaccine in hemodialysis patiens
Dr. Ali KOŞAR*,Dr.Mahmut DALMAZ*, Dr.Hakkı POLAT*, Dr.F.Nurten YEKSAN**, Dr.Süleyman TÜRK*, Dr.Mehdi YEKSAN*
.
Abstract
22 male. 14 female hemodialysis patients (HP) were included in this study. 20 microgram recombinant Hepatit B vaccine were given at 0. 1st and 6th months in deltoid muscle. The level of anti-HBs, C3, ( 4. Total lg(i were ¡jerjbrmed by ELISA. Total lymphocytes count were jierformed by Techinon IH 0.05. But there was no correlation between weight, sex, anti-HCl' antibody ¡xisitivity, duration of dialysis, abnormal liver functions, C3, ('4, TH lymphoiytes. T4:T8 ratio and immun resimse to he/ıatitis B vaccination in ///*. ¡Journal of Turgut Özal MedicaİCenter l(4):263-26~./994]
Key Words: Hemodialysis, hepatitis B vaccine, immun deficiency
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
